Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.
Lobato CMO, Codes L, Silva GF, Souza AFM, Coelho HSM, Pedroso MLA, Parise ER, Lima LMSTB, Borba LA, Evangelista AS, Rezende REF, Cheinquer H, Kuniyoshi ASO, Aires RS, Quintela EHD, Mendes LSC, Nascimento FCV, Medeiros Filho JEM, Ferraz MLCG, Abdala E, Bittencourt PL; Members of the Brazilian Real-Life Study about HCV treatment; Members of the Brazilian Real-Life Study about HCV treatment. Lobato CMO, et al. Among authors: mendes lsc. Ann Hepatol. 2019 Nov-Dec;18(6):849-854. doi: 10.1016/j.aohep.2019.08.001. Epub 2019 Aug 30. Ann Hepatol. 2019. PMID: 31537509 Free article.
Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: mendes lsc. Dig Dis Sci. 2022 Jul;67(7):3305-3312. doi: 10.1007/s10620-021-07122-y. Epub 2021 Jun 28. Dig Dis Sci. 2022. PMID: 34181166
Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population.
Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, Gomes NMF, de Oliveira EMG, Rotman V, de Oliveira MB, da Cunha SMCF, Mazo DFC, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, Pace FHL, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: mendes lsc. Ann Hepatol. 2022 Jan-Feb;27(1):100546. doi: 10.1016/j.aohep.2021.100546. Epub 2021 Sep 30. Ann Hepatol. 2022. PMID: 34600142 Free article.
Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study.
Cançado GGL, Couto CA, Guedes LV, Braga MH, Terrabuio DRB, Cançado ELR, Ferraz MLG, Villela-Nogueira CA, Nardelli MJ, Faria LC, de Oliveira EMG, Rotman V, Mazo DFC, Borges VFAE, Mendes LSC, Codes L, Pessoa MG, Signorelli IV, Levy C, Bittencourt PL. Cançado GGL, et al. Among authors: mendes lsc. Front Pharmacol. 2022 Jan 20;12:818089. doi: 10.3389/fphar.2021.818089. eCollection 2021. Front Pharmacol. 2022. PMID: 35126149 Free PMC article.
Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
Cançado GGL, Couto CA, Terrabuio DRB, Cançado ELR, Villela-Nogueira CA, Ferraz MLG, Braga MH, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Guedes LV, Signorelli IV, Coral GP, Levy C, Bittencourt PL; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: mendes lsc. Dig Dis Sci. 2023 Feb;68(2):514-520. doi: 10.1007/s10620-022-07654-x. Epub 2022 Aug 22. Dig Dis Sci. 2023. PMID: 35989386
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Braga MH, Cançado GGL, Bittencourt PL, Couto CA, Guedes LV, Lima AMC, Ferraz MLG, Villela-Nogueira CA, Nardelli MJ, Faria LC, Gomes NMF, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, Pace FHL, Pessoa MG, Signorelli IV, Coral GP, Filho JG, Chagas AL, Terrabuio DRB, Cançado ELR; Members of the Brazilian Cholestasis Study Group Consortium. Braga MH, et al. Among authors: mendes lsc. Ann Hepatol. 2023 Jul-Aug;28(4):101105. doi: 10.1016/j.aohep.2023.101105. Epub 2023 Apr 23. Ann Hepatol. 2023. PMID: 37088418 Free article.
BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR SYSTEMIC TREATMENT OF HEPATOCELLULAR CARCINOMA.
Chagas AL, Leal CRG, Mello VB, Barros FMDR, Bittencourt PL, Mattos AA, Aroucha D, Fonseca LGD, Silva JRL, Dottori MF, Teixeira R, Mendes LSC, Rezende REF, Filgueira NA, Coutinho AK, Araújo Neto JM, Coelho HSM, Pessoa MG, Cheinquer H, Parise ER, França A, Álvares-DA-Silva MR, Carrilho FJ, Coral GP, Pinto PTA, Pereira LMMB, Paraná R, Alves RCP, Brandão-Mello CE. Chagas AL, et al. Among authors: mendes lsc. Arq Gastroenterol. 2023 Jan-Mar;60(1):106-131. doi: 10.1590/S0004-2803.202301000-14. Arq Gastroenterol. 2023. PMID: 37194769 Free article.
A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score.
Cançado GGL, Gomes NMF, Couto CA, Cançado ELR, Terrabuio DRB, Villela-Nogueira CA, Braga MH, Nardelli MJ, Faria LC, Oliveira EMG, Rotman V, Oliveira MB, Cunha SMCFD, Mazo DFC, Mendes LSC, Ivantes CAP, Codes L, Borges VFAE, Pace FHL, Pessôa MG, Signorelli IV, Coral GP, Bittencourt PL, Fucuta P, Filho RJC, Ferraz MLG. Cançado GGL, et al. Among authors: mendes lsc. Eur J Gastroenterol Hepatol. 2024 May 1;36(5):628-635. doi: 10.1097/MEG.0000000000002744. Epub 2024 Mar 25. Eur J Gastroenterol Hepatol. 2024. PMID: 38555601
12 results